Chemical preconditioning-induced reactive astrocytosis contributes to the reduction of post-ischemic edema through aquaporin-4 downregulation

Experimental Neurology

Volumn 227, Issue 1, 2011, Pages 89-95

  Hoshi, Akihiko ^a   Yamamoto, Teiji ^a   Shimizu, Keiko ^a   Sugiura, Yoshihiro ^a   Ugawa, Yoshikazu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

3 Nitropropionic acid; Astrocyte; Brain edema; Ischemic tolerance; Neuroprotection

Indexed keywords

3 NITROPROPIONIC ACID; AQUAPORIN 4; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN SIZE; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; HEMISPHERE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; AQUAPORIN 4; ASTROCYTES; BRAIN; BRAIN EDEMA; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE-AMMONIA LIGASE; HYPOXIA-ISCHEMIA, BRAIN; ISCHEMIC PRECONDITIONING; MALE; NITROBENZOATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78650928328     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.09.016     Document Type: Article

References (43)

1. Amiry-Moghaddam M., Ottersen O.P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003, 4:991-1001.
2. Aoki K., Uchihara T., Tsuchiya K., Nakamura A., Ikeda K., Wakayama Y. Enhanced expression of aquaporin 4 in human brain with infarction. Acta Neuropathol. 2003, 106:121-124.
3. Aoki-Yoshino K., Uchihara T., Duyckaerts C., Nakamura A., Hauw J., Wakayama Y. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases. Acta Neuropathol. 2005, 110:281-288.
4. Badaut J., Lasbennes F., Magistretti P.J., Regli L. Aquaporins in brain: distribution, physiology, and pathophysiology. J. Cereb. Blood Flow Metab. 2002, 22:367-378.
5. Bardutzky J., Schwab S. Antiedema therapy in ischemic stroke. Stroke 2007, 38:3084-3094.
6. Borlongan C.V., Yamamoto M., Takei N., Kumazaki M., Ungsuparkorn C., Hida H., Sanberg P.R., Nishino H. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia. FASEB J. 2000, 14:1307-1317.
7. Brambrink A.M., Schneider A., Noga H., Astheimer A., Götz B., Körner I., Heimann A., Welschof M., Kempski O. Tolerance-inducing dose of 3-nitropropionic acid modulates bcl-2 and bax balance in the rat brain: a potential mechanism of chemical preconditioning. J. Cereb. Blood Flow Metab. 2000, 20:1425-1436.
8. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J. Neurochem. 2005, 95:1521-1540.
9. Calabresi P., Gubellini P., Picconi B., Centonze D., Pisani A., Bonsi P., Greengard P., Hipskind R.A., Borrelli E., Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J. Neurosci. 2001, 21:5110-5120.
10. Chen Y., Swanson R.A. Astrocytes and brain injury. J. Cereb. Blood Flow Metab. 2003, 23:137-149.
11. Coles C.J., Edmondson D.E., Singer T.P. Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 1979, 254:5161-5167.
12. Dirnagl U., Becker K., Meisel A. Preconditioning and tolerance against cerebral ischaemia: From experimental strategies to clinical use. Lancet Neurol. 2009, 8:398-412.
13. Friedman B., Schachtrup C., Tsai P.S., Shih A.Y., Akassoglou K., Kleinfeld D., Lyden P.D. Acute vascular disruption and aquaporin 4 loss after stroke. Stroke 2009, 40:2182-2190.
14. Gidday J.M. Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 2006, 7:437-448.
15. Hellweg R., von Arnim C.A.F., Büchner M., Huber R., Riepe M.W. Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation. Exp. Neurol. 2003, 183:346-354.
16. Hirt L., Ternon B., Price M., Mastour N., Brunet J.F., Bedaut J. Protective role of early aquaporin 4 induction against postischemic edema formation. J. Cereb. Blood Flow Metab. 2009, 29:423-433.
17. Horiguchi T., Kis B., Rajapakse N., Shimizu K., Busija D.W. Opening mitochondrial ATP-sensitive potassium channels is a trigger of 3-nitropropionic acid-induced tolerance to transient focal cerebral ischemia in rats. Stroke 2003, 34:1015-1020.
18. Hoshi A., Nakahara T., Ogata M., Yamamoto T. The critical threshold of 3-nitropropionic acid-induced ischemic tolerance in the rat. Brain Res. 2005, 1050:33-39.
19. Hoshi A., Nakahara T., Kayama H., Yamamoto T. Ischemic tolerance in chemical preconditioning: possible role of astrocytic glutamine synthetase buffering glutamate-mediated neurotoxicity. J. Neurosci. Res. 2006, 84:130-141.
20. Kirino T. Ischemic tolerance. J. Cereb. Blood Flow Metab. 2002, 22:1283-1296.
21. Lee T.S., Eid T., Mane S., Kim J.H., Spencer D.D., Ottersen O.P., de Lanerolle N.C. Aquaporin-4 is increased in the sclerotic hippocampus in human temporal lobe epilepsy. Acta Neuropathol. 2004, 108:493-502.
22. Li L., Lundkvist A., Andersson D., Wilhelmsson U., Nagai N., Pardo A.C., Nodin C., Ståhlberg A., Aprico K., Larsson K., Yabe T., Moons L., Fotheringham A., Davies I., Carmeliet P., Schwartz J.P., Pekna M., Kubista M., Blomstrand F., Maragakis N., Nilsson M., Pekny M. Protective role of reactive astrocytes in brain ischemia. J. Cereb. Blood Flow Metab. 2008, 28:468-481.
23. Manley G.T., Fujimura M., Ma T., Noshita N., Filiz F., Bollen A.W., Chan P., Verkman A.S. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 2000, 6:159-163.
24. Martinez-Hernandez A., Bell K.P., Norenberg M.D. Glutamine synthetase: glial localization in brain. Science 1977, 195:1356-1358.
25. Misu T., Fujihara K., Konno H., Nakamura M., Watanabe S., Takahashi T., Nakashima I., Takahashi H., Itoyama Y. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
26. Nakagawa I., Ogawa Y., Noriyama Y., Nakase H., Yamashita M., Sakai T. Chemical preconditioning prevents paradoxical increase in glutamate release during ischemia by activating ATP-dependent potassium channels in gerbil hippocampus. Exp. Neurol. 2003, 183:180-187.
27. Obrenovitch T.P. Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol. Rev. 2008, 88:211-247.
28. Papadopoulos M.C., Manley G.T., Krishna S., Verkman A.S. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J. 2004, 18:1291-1293.
29. Simard J.M., Kent T.A., Chen M., Tarasov K.V., Gerzanich V. Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications. Lancet Neurol. 2007, 6:258-268.
30. Sinclair C., Kirk J., Herron B., Fitzgerald U., McQuaid S. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 2007, 113:187-194.
31. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
32. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
33. Tait M.J., Saadoun S., Bell B.A., Papadopoulos M.C. Water movements in the brain: role of aquaporin. Trends Neurosci. 2008, 31:37-43.
34. Tamura A., Gotoh O., Sano K. Focal cerebral infarction in the rat. Part I: operative technique and physiological monitorings for chronic model (Japanese with English abstract). Brain Nerve 1986, 38:747-751.
35. Teunissen C.E., Steinbusch H.W.M., Angevaren M., Appels M., de Bruijn C., Prickaerts J., de Vente J. Behavioral correlates of striatal glial fibrillary acidic protein in the 3-nitropropionic acid rat model: disturbed walking pattern and spatial orientation. Neuroscience 2001, 105:153-167.
36. Trendelenburg G., Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 2005, 50:307-320.
37. Wang Y., Hatton G.I. Astrocytic plasticity and patterned oxytocin neuronal activity: dynamic interactions. J. Neurosci. 2009, 29:1743-1754.
38. Wiegand F., Liao W., Busch C., Castell S., Knapp F., Lindauer U., Megow D., Meisel A., Redetzky A., Ruscher K., Trendelenburg G., Victorov I., Riepe M., Diener H.C., Dirnagl U. Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1999, 19:1229-1237.
39. Xi G., Keep R.F., Hua Y., Xiang J., Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 1999, 30:1247-1255.
40. Yamamoto H., Konno H., Yamamoto T., Ito K., Mizugaki M., Iwasaki Y. Glutamine synthetase of the human brain: purification and characterization. J. Neurochem. 1987, 49:603-609.
41. Yang B., Zador Z., Verkman A.S. Glial cell aquaporin-4 overexpression in transgenic mice accelerates cytotoxic brain swelling. J. Biol. Chem. 2008, 283:15280-15286.
42. Yool A.J. Aquaporins: multiple roles in the central nervous system. Neuroscientist 2007, 13:470-485.
43. Zou J., Wang Y.X., Dou F.F., Lü H.Z., Ma Z.W., Lu P.H., Xu X.M. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem. Int. 2010, 56:577-584.